US20210361843A1 - Medical fluid delivery system - Google Patents
Medical fluid delivery system Download PDFInfo
- Publication number
- US20210361843A1 US20210361843A1 US17/134,733 US202017134733A US2021361843A1 US 20210361843 A1 US20210361843 A1 US 20210361843A1 US 202017134733 A US202017134733 A US 202017134733A US 2021361843 A1 US2021361843 A1 US 2021361843A1
- Authority
- US
- United States
- Prior art keywords
- vial
- skirt
- adapter
- flexible bag
- assembly according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012530 fluid Substances 0.000 title description 9
- 239000003814 drug Substances 0.000 claims abstract description 31
- 229940079593 drug Drugs 0.000 claims abstract description 27
- 239000006193 liquid solution Substances 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 8
- 238000000502 dialysis Methods 0.000 claims description 25
- 230000003115 biocidal effect Effects 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 239000003242 anti bacterial agent Substances 0.000 claims description 8
- 230000000295 complement effect Effects 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000000126 substance Substances 0.000 abstract description 11
- 239000000243 solution Substances 0.000 description 9
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 238000001990 intravenous administration Methods 0.000 description 6
- 239000002699 waste material Substances 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 238000001631 haemodialysis Methods 0.000 description 2
- 230000000322 hemodialysis Effects 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000008155 medical solution Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000006067 antibiotic powder Substances 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
- A61M1/1668—Details of containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
- A61J1/065—Rigid ampoules, e.g. glass ampoules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1475—Inlet or outlet ports
- A61J1/1481—Inlet or outlet ports with connection retaining means, e.g. thread or snap-fit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2006—Piercing means
- A61J1/201—Piercing means having one piercing end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2055—Connecting means having gripping means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2089—Containers or vials which are to be joined to each other in order to mix their contents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
- A61M1/1666—Apparatus for preparing dialysates by dissolving solids
Definitions
- a medicine or like substance which may be provided in a vial or like container, is required to be added to a fresh supply of a medical solution contained separately within a flexible bag, pouch, or like container before the medical solution is utilized during a medical treatment.
- a bag is a dialysate bag adapted for being connected to a dialysis machine or the like and for being utilized in dialysis treatment.
- Dialysis is a life-support treatment for a patient suffering from kidney failure and may utilize a machine to filter harmful wastes, salt, and excess fluid from the patient's blood.
- Hemodialysis is a type of kidney dialysis in which blood is filtered using a dialyzer and dialysis machine
- peritoneal dialysis is a type of kidney dialysis in which blood is filtered inside the patient's body after the patient's abdomen is filled with a peritoneal dialysis solution.
- a dialyzer a filter of the machine.
- wastes and extra fluids are removed from the blood while permitting the blood to retain a proper balance of minerals, such as potassium and sodium.
- the dialyzer After the blood is cleaned by the dialyzer, it is returned to the patient's body via return tubing.
- Dialysate is a fluid or solution used during dialysis that helps remove unwanted waste products from the blood and helps return electrolytes and minerals to their proper levels in the patient's body.
- fresh dialysate and blood flow through the dialyzer and impurities filtered out of the blood are transferred into the flow of dialysate. Thereafter, the dialysate containing unwanted waste products and excess electrolytes exit the dialyzer and is discarded.
- a supply of fresh dialysate solution may be provided in a flexible bag or pouch (i.e., a so-called “dialysate bag”) that may be connected to a dialysis machine or the like.
- a medicine such as an antibiotic, is added to the dialysate solution within the bag before the bag is attached to a dialysis machine or the like.
- a procedure for injecting an antibiotic provided in powdered form into a dialysate bag may include the following basic steps.
- a vial containing the antibiotic powder and a separate vial containing a solution to mix with the powder are provided and the stopper within the mouth of each vial is wiped clean.
- a syringe is used to penetrate the stopper and extract fluid from one of the vials and then penetrate the stopper and inject the fluid into the vial containing the powder. This may be repeated several times as needed.
- the vial containing the powder and injected fluid is shaken to mix the powder and fluid.
- a syringe is then used to extract the mixture from the vial and inject it into a port or stopper provided on the dialysate bag.
- an assembly for adding a medication or like substance to a liquid solution contained in a flexible bag, pouch or container includes the flexible bag, an adapter extending from and communicating with a port of the flexible bag, and a locking device.
- the adapter has a skirt for engaging about a neck finish of a separate vial containing a medication.
- the skirt comprises an array of spaced apart resilient sections that permit the skirt to expand about the neck finish when being applied to the vial and then resiliently return to a normal condition in which the neck finish is gripped by the skirt of the adapter.
- the locking device is then engaged about the skirt in a locking position such that outward movement or expansion of the array of resilient sections of the skirt is prevented by the locking device.
- the assembly described above further includes a vial.
- the assembly includes a flexible bag containing a liquid solution, an adapter extending from the flexible bag, a locking device, and a vial containing a medication.
- the vial has a neck finish defining a mouth having a stopper.
- the adapter extends integrally from the flexible bag and has a skirt with an array of resilient sections for engaging and resiliently snapping onto the neck finish of the vial.
- the locking device can be secured about the skirt in a locking position that prevents outward movement of the array of resilient sections of the skirt and that thereby prevents disengagement of the vial from the adapter.
- a method of adding a medication or like substance to a liquid solution contained within a flexible bag, pouch or container is provided.
- An adapter connects the flexible bag containing the liquid solution to a separate vial containing the medication or like substance.
- the vial has a neck finish defining a mouth with a stopper, and the adapter extends integrally from the flexible bag, has a skirt with an array of resilient sections for engaging and resiliently snapping onto the neck finish of the vial.
- the adapter also includes a cannula which is positioned to pierce the stopper of the vial when the adapter is connected to the neck finish.
- a locking device is placed in a locking position about the skirt such that the locking device prevents outward movement of the array of resilient sections of the skirt thereby locking the skirt to the neck finish of the vial. Squeezing of the bag may then cause liquid solution to be forced into the vial, and after the liquid solution and medication is mixed within the vial, the mixture may be returned to the flexible bag via suction created when squeezing of the bag is released and/or with gravity.
- FIG. 1 is a perspective view of an adapter, locking ring, and a part of a flexible bag from which the adapter extends in accordance to an embodiment.
- FIG. 2 is a perspective view of the adapter and locking ring in a disengaged condition in accordance to an embodiment.
- FIG. 3 is a cross-sectional view along line 3 - 3 of FIG. 1 showing the locking ring in a locked position on the adapter in accordance to an embodiment.
- FIG. 4 is a cross-sectional view along line 4 - 4 of FIG. 3 .
- FIG. 5 is a perspective view of an end section of a flexible bag having an adapter and disconnected relative to a separate vial in accordance to an embodiment.
- FIG. 6 is a perspective view of the end section of the flexible bag of FIG. 5 in which the adapter is connected and locked to the vial.
- Embodiments are disclosed herein that provide an efficient and time consuming manner of delivering a medication to a liquid solution contained within a flexible bag and for subsequent use in a medical procedure, for instance, a dialysis treatment. These embodiments eliminate the delay in waiting for a medication to be added to a fresh supply of solution such as conventionally performed in a clean room, IV room, or like sterile environment, yet still enables sterility to be maintained during the transfer of the medication or like substance into the bag, for instance, in a patient treatment room where a dialysis session is to take place. These embodiments also provide a relatively easy process for adding a medication or like substance to a fresh supply of medical liquid solution to enable the process to be readily performed by patients and/or caregivers of patients with minimal training and require the use of less supplies and materials.
- FIG. 1 A part of a flexible bag 10 , such as a dialysate bag containing a fresh supply of dialysate solution, is shown in FIG. 1 .
- the bag 10 may be provided with a port 12 to which an adapter or vial interconnection device 14 communicates and/or is integrally provided.
- the adapter 14 is configured to engage about a neck finish of a vial and to be positively locked thereto with a locking device or ring 16 .
- the bag 10 may also include additional ports, such as an output port through which the liquid solution exits the bag 10 during a medical treatment.
- a typical vial 100 may be provided having a 20 mL or other internal capacity.
- the vial 100 may be made of glass, rigid plastic or other material and may have a generally cylindrical or other-shaped hollow body 102 for containing a medication or other substance in a powder or liquid form. See FIGS. 5 and 6 for an example of a vial 100 .
- An example of a medication contained by the vial 100 is an antibiotic.
- the vial 100 has a relatively narrow throat 104 forming by a neck finish 106 .
- the neck finish 106 defines a mouth of the vial in which a stopper or the like is provided to seal the medication within the vial 100 .
- the exterior portion of the neck finish 106 may include an outwardly extending neck ring 108 or other outwardly extending structure. The significance of the neck ring 108 or the like of the neck finish 106 is that it provides an underside surface 110 about which the adapter 14 can be latched to positively grip the neck finish 106 .
- the adapter 14 of the bag 10 has a generally cap-like structure intended to be mounted over the neck finish 106 of the vial 100 .
- the adapter 14 includes a disk-shaped upper wall 18 for extending over, engaging, and/or covering the mouth and/or stopper of the vial 100 and a relatively annular skirt 20 extending from a periphery of the upper wall 18 .
- the skirt 20 is intended to snap onto and about the neck finish 106 of the vial 100 .
- the shape and size of the upper wall 18 and skirt 20 of the adapter 14 are not limited and may be provided in any shape and size configured to correspond to the shape and size of the vial to be connected to the bag 10 .
- the skirt 20 includes an array of separate, circumferentially spaced-apart, generally arc-shaped sections or fingers 22 each having a free end with an in-turned flange 24 .
- Open slots 26 are formed and located between each pair of adjacent sections 22 to permit the sections 22 to spread apart in a radially outward expanded condition of the skirt 20 so that the in-turned flanges 24 can extend beyond the neck finish 106 and/or neck ring 108 of the vial 100 and be located in a position to latch underneath the underside surface 110 .
- each section 22 After the sections 22 are spread apart in an expanded condition and the neck finish 106 is fully received within the skirt 20 , each section 22 automatically and resiliently returns to its normal position thereby positioning the in-turned flanges 24 below the neck ring 108 of the vial 100 . In this condition, the flanges 24 latch the skirt 20 to neck finish 106 and thereby connect the adapter 14 to the vial 100 .
- the adapter 14 includes a locking device or ring 16 .
- the skirt 20 and locking ring 16 may each include a complementary set of spiral threads, 30 and 32 , respectively, that are able to be coupled together when the locking ring 16 is turned or rotated relative to the skirt 20 .
- the locking ring 16 When the locking ring 16 is fully applied to and tightened about the adapter (i.e., when the locking ring is fully screwed onto the skirt 20 ), the locking ring 16 abuts against the outer surfaces of the sections 22 of the skirt 20 and thereby prevents the sections 22 from being spread apart in a radially outward manner. For instance, see FIGS. 3 and 4 which show the locking position of the locking ring 16 on the adapter 14 . In this condition, the adapter 14 having been mounted on the neck finish 106 of the vial 100 is unable to be released from the vial and is securely and tightly connected thereto without concern of any unwanted separation, even when significant pressure is intentionally applied to the flexible bag 10 .
- the adapter 14 includes a relatively sharp-tipped cannula 28 extending from the upper wall 18 of the adapter 14 and centrally between the sections 22 of the skirt 20 .
- the cannula 28 penetrates into and through a stopper provided in the mouth of the vial and gains entry within the interior of the vial.
- a hollow channel 34 extends through the cannula 30 , the upper wall 18 , and an opposite end 36 of the adapter 14 in communication with the interior of the bag 10 .
- the hollow channel 34 provides a flow path between the bag 10 and connected vial 100 , and the upper wall 18 , skirt 20 , and locking ring 16 ensure a fluid-tight seal between the bag 10 and the vial 100 .
- a user may grip the adapter 14 in one hand and ensure that the locking ring 16 is sufficiently disengaged with the skirt 20 to permit the sections 22 of the skirt 20 to be able to spread apart as needed to accommodate a neck finish and/or neck ring of a vial.
- the adapter 14 may be held in a position above the fluid level contained within the bag, a sealing cap (not shown) provided on the cannula 28 (i.e., for closing the channel 32 of the adapter 14 ) may be removed, and the cannula may be wiped clean to ensure sterility.
- a vial 100 having a stopper located in the mouth of the vial may be held in the opposite hand of the user.
- the adapter 14 may then be forced onto the neck finish 106 of the vial 100 via a snapping motion during which the sections 22 of the skirt 20 spread outwardly to accommodate the neck ring 108 of the vial 100 and then automatically and resiliently return inward to their normal original position whereby the in-turned flanges 24 extend beneath the neck ring 108 of the vial 100 thereby latching the adapter 14 to the neck finish 106 .
- the locking ring 16 may be turned relative to the skirt 20 so that the locking ring 16 advances over the sections 22 of the skirt 20 to a locking position that prevents the sections 22 from unwanted outward deflection. In this condition, the adapter 14 is reliably locked to the neck finish 106 of the vial 100 and the vial cannot be released.
- the bag 10 may be squeezed to force liquid solution contained within the bag 10 through channel 34 defined by the adapter 14 into the vial 100 .
- the vial 100 may then be shaken to thoroughly mix the solution with the medicine and then the mixture may be caused to flow into the bag through channel 34 by the forces of suction created by releasing any squeezing of the bag 10 and/or by gravity by positioning the vial 100 above the bag 10 .
- the bag 10 is ready for use.
- the bag may contain dialysate with an added antibiotic and may be attached to a dialysate machine so that the dialysate with added antibiotic may be caused to flow through a dialyzer.
- the location of the adapter 14 on the bag 10 may be such that when the bag is connected to the dialysis machine the adapter 14 is located at the top of the bag 10 preventing flow of the solution into the vial.
- the vial 100 may remain attached to the bag 10 during dialysis treatment for safety purposes providing a clear indication as to the fact that the contents of the vial have already been added to the bag.
- the vial may be removed from the bag and the adapter sealed close. In this case, the sealing ring 16 needs to be unscrewed relative to the skirt to permit the sections of the skirt to unsnap from the neck finish of the vial.
- the adapter 14 , bag 10 as well as the vial may be readily recycled and/or properly discarded.
- the adapter 14 may be made of a recyclable plastic material or the like.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Fluid Mechanics (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
- This application is a continuation of co-pending U.S. application Ser. No. 15/780,280 which is a 371 National Stage of International Application No. PCT/US2016/064734, filed Dec. 2, 2016, which claims the benefit under 35 USC § 119(e) of U.S. Provisional Patent Application No. 62/262,841 filed Dec. 3, 2015, U.S. Provisional Patent Application No. 62/385,144 filed Sep. 8, 2016, and U.S. Provisional Patent Application No. 62/397,748 filed Sep. 21, 2016.
- In many instances, a medicine or like substance, which may be provided in a vial or like container, is required to be added to a fresh supply of a medical solution contained separately within a flexible bag, pouch, or like container before the medical solution is utilized during a medical treatment. An example of such a bag is a dialysate bag adapted for being connected to a dialysis machine or the like and for being utilized in dialysis treatment.
- Dialysis is a life-support treatment for a patient suffering from kidney failure and may utilize a machine to filter harmful wastes, salt, and excess fluid from the patient's blood. Hemodialysis is a type of kidney dialysis in which blood is filtered using a dialyzer and dialysis machine, and peritoneal dialysis is a type of kidney dialysis in which blood is filtered inside the patient's body after the patient's abdomen is filled with a peritoneal dialysis solution.
- During a hemodialysis session, for instance, blood flows from the patient via tubing through a special filter (a dialyzer) of the machine. As the blood flows through the filter, wastes and extra fluids are removed from the blood while permitting the blood to retain a proper balance of minerals, such as potassium and sodium. After the blood is cleaned by the dialyzer, it is returned to the patient's body via return tubing.
- Dialysate is a fluid or solution used during dialysis that helps remove unwanted waste products from the blood and helps return electrolytes and minerals to their proper levels in the patient's body. Thus, during a dialysis treatment, fresh dialysate and blood flow through the dialyzer and impurities filtered out of the blood are transferred into the flow of dialysate. Thereafter, the dialysate containing unwanted waste products and excess electrolytes exit the dialyzer and is discarded.
- A supply of fresh dialysate solution may be provided in a flexible bag or pouch (i.e., a so-called “dialysate bag”) that may be connected to a dialysis machine or the like. In many cases, a medicine, such as an antibiotic, is added to the dialysate solution within the bag before the bag is attached to a dialysis machine or the like.
- By way of example, a procedure for injecting an antibiotic provided in powdered form into a dialysate bag may include the following basic steps. A vial containing the antibiotic powder and a separate vial containing a solution to mix with the powder are provided and the stopper within the mouth of each vial is wiped clean. A syringe is used to penetrate the stopper and extract fluid from one of the vials and then penetrate the stopper and inject the fluid into the vial containing the powder. This may be repeated several times as needed. Thereafter, the vial containing the powder and injected fluid is shaken to mix the powder and fluid. A syringe is then used to extract the mixture from the vial and inject it into a port or stopper provided on the dialysate bag.
- Complicating this conventional procedure is the necessity to perform the above discussed tasks in a separate clean room or IV room of a hospital or like treatment facility and not within the room in which dialysis treatment actually occurs. Thus, according to conventional practice, a fresh supply of dialysate contained within a bag is taken to a sterile IV room (i.e., a room in hospital or like facility for the sterile preparation of intravenous (IV) medications) where antibiotics are added to the dialysate bag. However, this may take approximately 20 minutes to up to 2 hours depending upon work load and available personnel within the IV room. The bag is ultimately returned to the nurse or other caregiver responsible for setting up the dialysis machine and only then may the dialysis treatment be started.
- According to an embodiment, an assembly for adding a medication or like substance to a liquid solution contained in a flexible bag, pouch or container is provided. The assembly includes the flexible bag, an adapter extending from and communicating with a port of the flexible bag, and a locking device. The adapter has a skirt for engaging about a neck finish of a separate vial containing a medication. The skirt comprises an array of spaced apart resilient sections that permit the skirt to expand about the neck finish when being applied to the vial and then resiliently return to a normal condition in which the neck finish is gripped by the skirt of the adapter. The locking device is then engaged about the skirt in a locking position such that outward movement or expansion of the array of resilient sections of the skirt is prevented by the locking device.
- According to another embodiment, the assembly described above further includes a vial. Thus, the assembly includes a flexible bag containing a liquid solution, an adapter extending from the flexible bag, a locking device, and a vial containing a medication. The vial has a neck finish defining a mouth having a stopper. The adapter extends integrally from the flexible bag and has a skirt with an array of resilient sections for engaging and resiliently snapping onto the neck finish of the vial. The locking device can be secured about the skirt in a locking position that prevents outward movement of the array of resilient sections of the skirt and that thereby prevents disengagement of the vial from the adapter.
- According to another aspect of the embodiment, a method of adding a medication or like substance to a liquid solution contained within a flexible bag, pouch or container is provided. An adapter connects the flexible bag containing the liquid solution to a separate vial containing the medication or like substance. The vial has a neck finish defining a mouth with a stopper, and the adapter extends integrally from the flexible bag, has a skirt with an array of resilient sections for engaging and resiliently snapping onto the neck finish of the vial. The adapter also includes a cannula which is positioned to pierce the stopper of the vial when the adapter is connected to the neck finish. After the adapter is connected to the vial, a locking device is placed in a locking position about the skirt such that the locking device prevents outward movement of the array of resilient sections of the skirt thereby locking the skirt to the neck finish of the vial. Squeezing of the bag may then cause liquid solution to be forced into the vial, and after the liquid solution and medication is mixed within the vial, the mixture may be returned to the flexible bag via suction created when squeezing of the bag is released and/or with gravity.
- Various features of the embodiments described in the following detailed description can be more fully appreciated when considered with reference to the accompanying figures, wherein the same numbers refer to the same elements.
-
FIG. 1 is a perspective view of an adapter, locking ring, and a part of a flexible bag from which the adapter extends in accordance to an embodiment. -
FIG. 2 is a perspective view of the adapter and locking ring in a disengaged condition in accordance to an embodiment. -
FIG. 3 is a cross-sectional view along line 3-3 ofFIG. 1 showing the locking ring in a locked position on the adapter in accordance to an embodiment. -
FIG. 4 is a cross-sectional view along line 4-4 ofFIG. 3 . -
FIG. 5 is a perspective view of an end section of a flexible bag having an adapter and disconnected relative to a separate vial in accordance to an embodiment. -
FIG. 6 is a perspective view of the end section of the flexible bag ofFIG. 5 in which the adapter is connected and locked to the vial. - For simplicity and illustrative purposes, principles of embodiments are described below by referring primarily to examples thereof. In the following description, numerous specific details are set forth to provide a thorough understanding of the embodiments. It will be apparent to one of ordinary skill in the art that the embodiments may be practiced without limitation to these specific details. In some instances, well known methods and structures have not been described in detail so as not to unnecessarily obscure the embodiments.
- Embodiments are disclosed herein that provide an efficient and time consuming manner of delivering a medication to a liquid solution contained within a flexible bag and for subsequent use in a medical procedure, for instance, a dialysis treatment. These embodiments eliminate the delay in waiting for a medication to be added to a fresh supply of solution such as conventionally performed in a clean room, IV room, or like sterile environment, yet still enables sterility to be maintained during the transfer of the medication or like substance into the bag, for instance, in a patient treatment room where a dialysis session is to take place. These embodiments also provide a relatively easy process for adding a medication or like substance to a fresh supply of medical liquid solution to enable the process to be readily performed by patients and/or caregivers of patients with minimal training and require the use of less supplies and materials.
- A part of a
flexible bag 10, such as a dialysate bag containing a fresh supply of dialysate solution, is shown inFIG. 1 . Thebag 10 may be provided with aport 12 to which an adapter orvial interconnection device 14 communicates and/or is integrally provided. Theadapter 14 is configured to engage about a neck finish of a vial and to be positively locked thereto with a locking device orring 16. Thebag 10 may also include additional ports, such as an output port through which the liquid solution exits thebag 10 during a medical treatment. - By way of example and not by way of limitation, a
typical vial 100 may be provided having a 20 mL or other internal capacity. Thevial 100 may be made of glass, rigid plastic or other material and may have a generally cylindrical or other-shapedhollow body 102 for containing a medication or other substance in a powder or liquid form. SeeFIGS. 5 and 6 for an example of avial 100. An example of a medication contained by thevial 100 is an antibiotic. - The
vial 100 has a relativelynarrow throat 104 forming by aneck finish 106. Theneck finish 106 defines a mouth of the vial in which a stopper or the like is provided to seal the medication within thevial 100. The exterior portion of theneck finish 106 may include an outwardly extendingneck ring 108 or other outwardly extending structure. The significance of theneck ring 108 or the like of theneck finish 106 is that it provides anunderside surface 110 about which theadapter 14 can be latched to positively grip theneck finish 106. - The
adapter 14 of thebag 10 has a generally cap-like structure intended to be mounted over theneck finish 106 of thevial 100. Thus, theadapter 14 includes a disk-shapedupper wall 18 for extending over, engaging, and/or covering the mouth and/or stopper of thevial 100 and a relativelyannular skirt 20 extending from a periphery of theupper wall 18. Theskirt 20 is intended to snap onto and about theneck finish 106 of thevial 100. Thus, the shape and size of theupper wall 18 andskirt 20 of theadapter 14 are not limited and may be provided in any shape and size configured to correspond to the shape and size of the vial to be connected to thebag 10. - As best shown in
FIG. 2 , theskirt 20 includes an array of separate, circumferentially spaced-apart, generally arc-shaped sections orfingers 22 each having a free end with an in-turnedflange 24.Open slots 26 are formed and located between each pair ofadjacent sections 22 to permit thesections 22 to spread apart in a radially outward expanded condition of theskirt 20 so that the in-turnedflanges 24 can extend beyond theneck finish 106 and/orneck ring 108 of thevial 100 and be located in a position to latch underneath theunderside surface 110. After thesections 22 are spread apart in an expanded condition and theneck finish 106 is fully received within theskirt 20, eachsection 22 automatically and resiliently returns to its normal position thereby positioning the in-turnedflanges 24 below theneck ring 108 of thevial 100. In this condition, theflanges 24 latch theskirt 20 toneck finish 106 and thereby connect theadapter 14 to thevial 100. - Unintended disconnection of the vial from the adapter described above is possible, for instance, when the
bag 10 is squeezed as discussed below or during use in a medical treatment. Thus, for purposes of ensuring that thevial 100 does not become disengaged with theadapter 14, theadapter 14 includes a locking device orring 16. For example, theskirt 20 and lockingring 16 may each include a complementary set of spiral threads, 30 and 32, respectively, that are able to be coupled together when the lockingring 16 is turned or rotated relative to theskirt 20. When the lockingring 16 is fully applied to and tightened about the adapter (i.e., when the locking ring is fully screwed onto the skirt 20), the lockingring 16 abuts against the outer surfaces of thesections 22 of theskirt 20 and thereby prevents thesections 22 from being spread apart in a radially outward manner. For instance, seeFIGS. 3 and 4 which show the locking position of the lockingring 16 on theadapter 14. In this condition, theadapter 14 having been mounted on theneck finish 106 of thevial 100 is unable to be released from the vial and is securely and tightly connected thereto without concern of any unwanted separation, even when significant pressure is intentionally applied to theflexible bag 10. - The
adapter 14 includes a relatively sharp-tippedcannula 28 extending from theupper wall 18 of theadapter 14 and centrally between thesections 22 of theskirt 20. Thus, when theskirt 20 of theadapter 14 is applied about a neck finish of a vial, thecannula 28 penetrates into and through a stopper provided in the mouth of the vial and gains entry within the interior of the vial. Ahollow channel 34 extends through thecannula 30, theupper wall 18, and anopposite end 36 of theadapter 14 in communication with the interior of thebag 10. Thus, thehollow channel 34 provides a flow path between thebag 10 andconnected vial 100, and theupper wall 18,skirt 20, and lockingring 16 ensure a fluid-tight seal between thebag 10 and thevial 100. - Accordingly, when a medication or like substance, such as an antibiotic in powder or liquid form, is desired to be added to the liquid solution contained within the
flexible bag 10, a user may grip theadapter 14 in one hand and ensure that the lockingring 16 is sufficiently disengaged with theskirt 20 to permit thesections 22 of theskirt 20 to be able to spread apart as needed to accommodate a neck finish and/or neck ring of a vial. Theadapter 14 may be held in a position above the fluid level contained within the bag, a sealing cap (not shown) provided on the cannula 28 (i.e., for closing thechannel 32 of the adapter 14) may be removed, and the cannula may be wiped clean to ensure sterility. Avial 100 having a stopper located in the mouth of the vial may be held in the opposite hand of the user. - The
adapter 14 may then be forced onto theneck finish 106 of thevial 100 via a snapping motion during which thesections 22 of theskirt 20 spread outwardly to accommodate theneck ring 108 of thevial 100 and then automatically and resiliently return inward to their normal original position whereby the in-turnedflanges 24 extend beneath theneck ring 108 of thevial 100 thereby latching theadapter 14 to theneck finish 106. Thereafter, the lockingring 16 may be turned relative to theskirt 20 so that the lockingring 16 advances over thesections 22 of theskirt 20 to a locking position that prevents thesections 22 from unwanted outward deflection. In this condition, theadapter 14 is reliably locked to theneck finish 106 of thevial 100 and the vial cannot be released. - For purposes of mixing the liquid solution in the
bag 10 with the medication or like substance contained in thevial 100, thebag 10 may be squeezed to force liquid solution contained within thebag 10 throughchannel 34 defined by theadapter 14 into thevial 100. Thevial 100 may then be shaken to thoroughly mix the solution with the medicine and then the mixture may be caused to flow into the bag throughchannel 34 by the forces of suction created by releasing any squeezing of thebag 10 and/or by gravity by positioning thevial 100 above thebag 10. - After the mixture has been received within the
bag 10, thebag 10 is ready for use. For example, the bag may contain dialysate with an added antibiotic and may be attached to a dialysate machine so that the dialysate with added antibiotic may be caused to flow through a dialyzer. The location of theadapter 14 on thebag 10 may be such that when the bag is connected to the dialysis machine theadapter 14 is located at the top of thebag 10 preventing flow of the solution into the vial. Also, thevial 100 may remain attached to thebag 10 during dialysis treatment for safety purposes providing a clear indication as to the fact that the contents of the vial have already been added to the bag. Alternatively, the vial may be removed from the bag and the adapter sealed close. In this case, the sealingring 16 needs to be unscrewed relative to the skirt to permit the sections of the skirt to unsnap from the neck finish of the vial. - After use, the
adapter 14,bag 10 as well as the vial may be readily recycled and/or properly discarded. For instance, theadapter 14 may be made of a recyclable plastic material or the like. - While the principles of the invention have been described above in connection with specific devices, assemblies, and methods, it is to be clearly understood that this description is made only by way of example and not by way of limitation. For instance, while a dialysate bag added with an antibiotic in powder form for use in a dialysis machine is described above, the bag may contain any type of solution and be added within any type of medicine, drug, or other additive or agent in any form. Also, while an annular shaped skirt and locking ring are shown, other shaped skirts and locking devices that are not circular may be utilized. Still further, the locking device may be secured to the skirt with mechanisms other than spiral threads, such as by friction, the use of a separate clip or band, or the like.
- Thus, one of ordinary skill in the art will appreciate that various modifications and changes can be made without departing from the scope of the claims below. Accordingly, the specification and figures are to be regarded in an illustrative rather than a restrictive sense, and all such modifications are intended to be included within the scope of the present invention.
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/134,733 US20210361843A1 (en) | 2015-12-03 | 2020-12-28 | Medical fluid delivery system |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562262841P | 2015-12-03 | 2015-12-03 | |
US201662385144P | 2016-09-08 | 2016-09-08 | |
US201662397748P | 2016-09-21 | 2016-09-21 | |
PCT/US2016/064734 WO2017096238A1 (en) | 2015-12-03 | 2016-12-02 | Medical fluid delivery system |
US201815780280A | 2018-05-31 | 2018-05-31 | |
US17/134,733 US20210361843A1 (en) | 2015-12-03 | 2020-12-28 | Medical fluid delivery system |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/780,280 Continuation US10874789B2 (en) | 2015-12-03 | 2016-12-02 | Medical fluid delivery system |
PCT/US2016/064734 Continuation WO2017096238A1 (en) | 2015-12-03 | 2016-12-02 | Medical fluid delivery system |
Publications (1)
Publication Number | Publication Date |
---|---|
US20210361843A1 true US20210361843A1 (en) | 2021-11-25 |
Family
ID=58797954
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/780,280 Active 2037-09-07 US10874789B2 (en) | 2015-12-03 | 2016-12-02 | Medical fluid delivery system |
US17/134,733 Pending US20210361843A1 (en) | 2015-12-03 | 2020-12-28 | Medical fluid delivery system |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/780,280 Active 2037-09-07 US10874789B2 (en) | 2015-12-03 | 2016-12-02 | Medical fluid delivery system |
Country Status (2)
Country | Link |
---|---|
US (2) | US10874789B2 (en) |
WO (1) | WO2017096238A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017096238A1 (en) * | 2015-12-03 | 2017-06-08 | Drexel University | Medical fluid delivery system |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10874789B2 (en) * | 2015-12-03 | 2020-12-29 | Drexel University | Medical fluid delivery system |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3788369A (en) | 1971-06-02 | 1974-01-29 | Upjohn Co | Apparatus for transferring liquid between a container and a flexible bag |
US4458733A (en) | 1982-04-06 | 1984-07-10 | Baxter Travenol Laboratories, Inc. | Mixing apparatus |
JPS6040067A (en) * | 1983-08-15 | 1985-03-02 | テルモ株式会社 | Medical container |
US4607671A (en) | 1984-08-21 | 1986-08-26 | Baxter Travenol Laboratories, Inc. | Reconstitution device |
US4759756A (en) | 1984-09-14 | 1988-07-26 | Baxter Travenol Laboratories, Inc. | Reconstitution device |
US4898209A (en) | 1988-09-27 | 1990-02-06 | Baxter International Inc. | Sliding reconstitution device with seal |
US5304163A (en) | 1990-01-29 | 1994-04-19 | Baxter International Inc. | Integral reconstitution device |
US5893397A (en) | 1996-01-12 | 1999-04-13 | Bioject Inc. | Medication vial/syringe liquid-transfer apparatus |
DE69832766T2 (en) | 1997-09-25 | 2006-09-21 | Becton Dickinson France S.A. | Connector with locking ring for a vial |
AR021220A1 (en) | 1998-09-15 | 2002-07-03 | Baxter Int | CONNECTION DEVICE FOR ESTABLISHING A FLUID COMMUNICATION BETWEEN A FIRST CONTAINER AND A SECOND CONTAINER. |
FR2817465B1 (en) | 2000-12-06 | 2003-04-25 | Technoflex Sa | RECONSTRUCTION DEVICE, PARTICULARLY FOR MIXING SUBSTANCES IN THE MEDICAL FIELD |
US8562583B2 (en) | 2002-03-26 | 2013-10-22 | Carmel Pharma Ab | Method and assembly for fluid transfer and drug containment in an infusion system |
US7935070B2 (en) * | 2005-01-28 | 2011-05-03 | Fresenius Medical Care North America | Systems and methods for dextrose containing peritoneal dialysis (PD) solutions with neutral pH and reduced glucose degradation product |
US20100237011A1 (en) | 2009-03-20 | 2010-09-23 | Edward Allan Ross | Blood treatment systems and related methods |
BR122012017389B8 (en) | 2009-07-01 | 2021-06-22 | Fresenius Medical Care Holdings Inc | drug delivery device |
US20130053814A1 (en) * | 2010-01-15 | 2013-02-28 | Bayer Healthcare Llc | Device |
US8721612B2 (en) | 2010-12-17 | 2014-05-13 | Hospira, Inc. | System and method for intermixing the contents of two containers |
IL215699A0 (en) | 2011-10-11 | 2011-12-29 | Medimop Medical Projects Ltd | Liquid drug reconstitution assemblage for use with iv bag and drug vial |
BR112014017681A8 (en) * | 2012-01-19 | 2017-07-11 | Baxter Int | METHOD AND COMPOSITION FOR THE REMOVAL OF UREMIC TOXINS IN DIALYSIS PROCESSES |
ITMI20120643A1 (en) | 2012-04-18 | 2013-10-19 | Frattini Paolo Giuseppe Gobbi | BAG FOR LIQUID SOLUTIONS THAT CAN BE MIXED WITH ACTIVE SUBSTANCES AVAILABLE IN SEPARATE SHAPE, IN POWDER OR GEL IN PARTICULAR, FOR THE FORMATION OF MEDICINAL OR LIQUID NUTRITIONAL SUBSTANCES ADMINISTABLE TO PATIENTS FOR INTERNAL INSTILLATION. |
-
2016
- 2016-12-02 WO PCT/US2016/064734 patent/WO2017096238A1/en active Application Filing
- 2016-12-02 US US15/780,280 patent/US10874789B2/en active Active
-
2020
- 2020-12-28 US US17/134,733 patent/US20210361843A1/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10874789B2 (en) * | 2015-12-03 | 2020-12-29 | Drexel University | Medical fluid delivery system |
Also Published As
Publication number | Publication date |
---|---|
WO2017096238A1 (en) | 2017-06-08 |
US10874789B2 (en) | 2020-12-29 |
US20180344916A1 (en) | 2018-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2337543B1 (en) | System for reconstitution of a powdered drug | |
US20230355475A1 (en) | Pooling device for single or multiple medical containers | |
US10207099B1 (en) | Closure assembly for medical fitting | |
US5566729A (en) | Drug reconstitution and administration system | |
US8529502B2 (en) | Transfer system for forming a drug solution from a lyophilized drug | |
CA2215912C (en) | Pre-filled syringe drug delivery system | |
US20240108548A1 (en) | Pre-filled diluent syringe vial adapter | |
US7882863B2 (en) | Apparatus and method for mixing and transferring medications | |
US9402786B2 (en) | Device/system for mixing liquids, drugs and solutions before administration into the human body | |
AU2018316283B2 (en) | Reconstitution device, system, and method to administer a drug in a moderate bolus | |
US20140246342A1 (en) | System and Method for Intermixing the Contents of Two Containers | |
WO2008009288A1 (en) | Connector device and method for sterile mixing | |
KR20220002472A (en) | Liquid Delivery Device With Dual Lumen IV Spike | |
US20210361843A1 (en) | Medical fluid delivery system | |
JP7209849B2 (en) | Liquid transfer device for use with IV bottles | |
KR102720115B1 (en) | Pooling device for single or multiple containers | |
JP2001178831A (en) | Connecting instrument and connecting tool for liquid medicine container | |
KR20240154676A (en) | Pooling device for single or multiple containers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NEW YORK UNIVERSITY, NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CHOPRA, ARUN;REEL/FRAME:057169/0136 Effective date: 20161019 Owner name: DREXEL UNIVERSITY, PENNSYLVANIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CIES, JEFFERY JOHN;NOH, MOSES;SIGNING DATES FROM 20161019 TO 20170215;REEL/FRAME:057169/0050 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |